CNN 16 Nov 2020

Moderna's Covid-19 vaccine is 94.5% effective, according to company data


Moderna said today its coronavirus vaccine is 94.5% effective, similar to early results released by Pfizer last week, making it the second vaccine in the US to have a stunningly high success rate. Noubar Afeyan, Moderna co-founder and chairman, says the company's innovations enable it to "keep the vaccine under refrigeration conditions for up to 30 days," enabling broad distribution.

American pharmaceutical company Moderna announced on Monday that its COVID-19 vaccine candidate is nearly 95% effective. The news comes one week after Pfizer announced its inoculations are also successful. CBS News chief medical correspondent Dr. Jon LaPook has the latest.
A Covid-19 vaccine is nearly in our grasp. That should give Americans an incentive to hold on a little longer and double down on our resolve to protect the health of others. "We can do this," Lester Holt says. "For all of our sakes."
With infections surging worldwide, and governments struggling to respond, there has been another breakthrough in the hunt for a COVID-19 vaccine.
US pharmaceutical firm Moderna says early tests show its vaccine is 94.5 percent effective in preventing the virus.
Pfizer and BioNTech reported similarly promising results a week ago.

Al Jazeera's Alan Fisher reports from the US capital, Washington, DC.
Biotech company Moderna said on Monday that early analysis from its phase 3 trial shows its Covid-19 vaccine is 94.5 percent effective at preventing the infection, offering hope of a second breakthrough in as many weeks. Aired on 11/16/2020.

Share Video:

Embed Video: